Your account is not claimed yet. You can sign up with ORCID to claim your account.

Ke-Jia Kan (Kejia Kan)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Venues

Biomedicines

Cancers

Genes

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Feng Guo, Ke-Jia Kan, Felix Rückert, Wolfgang Rückert, Lin Li, Johannes Eberhard, Tobias May, Carsten Sticht, Wilhelm Gerhard Dirks, Christoph Reissfelder, Prama Pallavi, Michael Keese
Comparison of Tumour-Specific Phenotypes in Human Primary and Expandable Pancreatic Cancer Cell Lines. International journal of molecular sciences 24 (17) (2023)
Lin Li, Ke-Jia Kan, Prama Pallavi, Michael Keese
Identification of the Key Genes and Potential Therapeutic Compounds for Abdominal Aortic Aneurysm Based on a Weighted Correlation Network Analysis. Biomedicines 10 (5) (2022)
Zhaohui Wang, Ziwei Zeng, Vytaute Starkuviene, Holger Erfle, Ke-Jia Kan, Jian Zhang, Manuel Gunkel, Carsten Sticht, Nuh Rahbari, Michael Keese
MicroRNAs Influence the Migratory Ability of Human Umbilical Vein Endothelial Cells. Genes 13 (4) (2022)
Ke-Jia Kan, Yifei Mu, Marielle Bouschbacher, Carsten Sticht, Natalia Kuch, Martin Sigl, Nuh Rahbari, Norbert Gretz, Prama Pallavi, Michael Keese
Biphasic Effects of Blue Light Irradiation on Human Umbilical Vein Endothelial Cells. Biomedicines 9 (7) (2021)
Ke-Jia Kan, Feng Guo, Lei Zhu, Prama Pallavi, Martin Sigl, Michael Keese
Weighted Gene Co-Expression Network Analysis Reveals Key Genes and Potential Drugs in Abdominal Aortic Aneurysm. Biomedicines 9 (5) (2021)
Lei Zhu, Ke-Jia Kan, Johanna L Grün, Barbara Hissa, Cui Yang, Balázs Győrffy, Sonja Loges, Christoph Reissfelder, Sebastian Schölch
GAS2L1 Is a Potential Biomarker of Circulating Tumor Cells in Pancreatic Cancer. Cancers 12 (12) (2020)

Ke-Jia Kan.css-eqlu8i{font-size:small;padding-left:4px;} (Kejia Kan)

Publication Activity (10 Years)

Top Topics

Top Venues

Ke-Jia Kan (Kejia Kan)